semaglutide weight loss carmel Semaglutide: A Breakthrough Understanding GLP-1 and Its Role

December 2, 2024: Lawsuits Against Wegovy and other GLP-1 Drugs Grow to 1,300 in November Wegovy manufacturer Novo Nordisk is facing a growing number of lawsuits alleging the weight-loss drug led to serious side effects like blood clots, vision loss, and gastrointestinal disorders

Vegetarian & Natural: Made with all-natural ingredients and encased in vegetarian capsules for wider dietary acceptance

December 22, 1998

What to expect during GLP-1/Tizerpatide consultation

The fundamental issue is that the skin barrier prevents the absorption of weight loss compounds at levels that could meaningfully affect appetite or metabolism

In theory, 16-OHE 1 could also bind DNA, although this has not been observed